论文部分内容阅读
１９９９年２～６月，我们应用酶联免疫反应法测定了１６例急性脑梗塞患者的血浆可溶性细胞间粘附分子（ｓＩＣＡＭ－１）和可溶性血管细胞粘附分子（ｓＶＣＡＭ－１）含量变化，旨在探讨其在急性脑梗塞发病中的作用。１ 资料与方法１．１ 临床资料 患者组男２例，女１４例；年
From February to June 1999, we measured the changes of plasma soluble intercellular adhesion molecule (sICAM-1) and soluble vascular cell adhesion molecule (sVCAM-1) in 16 patients with acute cerebral infarction by enzyme-linked immunosorbent assay To explore its role in the pathogenesis of acute cerebral infarction. 1 Materials and Methods 1.1 Clinical data Patient group 2 males and 14 females;